Stephen Ruoss

Publication Details

• Diagnosing invasive fungal disease in critically ill patients.

  Hsu JL, Ruoss SJ, Bower ND, Lin M, Holodniy M, Stevens DA. Crit Rev Microbiol. 2011; 37 (4): 277-312

  Fungal infections are increasing, with a changing landscape of pathogens and emergence of new groups at risk for invasive disease. We review current diagnostic techniques, focusing on studies in critically ill patients. Microbiological cultures, the current "gold standard", demonstrate poor sensitivity, thus diagnosis of invasive disease in the critically ill is difficult. This diagnostic dilemma results in under- or over-treatment of patients, potentially contributing to poor outcomes and antifungal resistance. While other current diagnostic tests perform moderately well, many lack timeliness, efficacy, and are negatively affected by treatments common to critically ill patients. New nucleic acid-based research is promising.

  PubMedID: 21749278